StockTipsArenaBeta

BUY Indegene Limited — Axis Securities

BUYIndegene Limited
Indegene share price target & all analyst calls

byAxis SecuritiesHorizon: NA (inferred 1–3 months)23 Sept 2026via Economic Times New Stock Recos

Entry₹598Inferred
Target₹705
Total upside +17.89%
Stop lossNot given
CMP₹666.21d ago
Active+11.40%+5.82%upside left 6 wk left
Follow Axis Securities for new calls(33% target hit, 12 closed calls)Get alertsWatch INDGN for new buy/sell callsGet alertsSee 84 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:23 am IST
5 supporting6 neutral1 opposing
Supports the BUY call (5)

MACD above its signal line — bullish momentum

Technicals · macd·14 Nov · today

Past month's volume 1.3× the prior month's average

Technicals · volume·13 Nov · yesterday

4 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·2 Nov · 2w ago

Indegene reported strong Q2 FY27 performance with H1 USD revenue growth reaching a four-year high.

NSE · Press Release·29 Oct · 2w ago

(opens in new tab)

Indegene reported Q2 FY27 revenue of INR 11,223 million, up 39.5% YoY, with EBITDA of INR 1,873 million and PAT of INR 1,123 million, reflecting strong growth and stable margins.

BSE · Company Update·29 Oct · 2w ago

(opens in new tab)
Neutral / worth noting (6)

Indegene Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·29 Oct · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

RSI at 73 — overbought territory

Technicals · rsi·14 Nov · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Indegene

All analyst calls on Indegene

More from Axis Securities

Every call and its outcome